<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SGHT
Sight Sciences
$
()


  • Sight Sciences publishes results from MIGS study in AJO

    4/10/2024 - 16:19pm
  • Fly Intel: Pre-Market Movers

    4/3/2024 - 08:41am
  • Fly Intel: After-Hours Movers

    4/2/2024 - 18:04pm
  • Sight Sciences to present GEMINI trial data at ASCRS

    4/2/2024 - 17:53pm
  • Sight Sciences reports Q4 EPS (22c), consensus (32c)

    3/7/2024 - 16:33pm
  • Sight Sciences launches Ergo-Series of OMNI Surgical System in Europe

    2/14/2024 - 16:50pm
  • Sight Sciences price target raised by $2.50 at Piper Sandler, here's why

    1/16/2024 - 07:40am
  • Sight Sciences sees FY23 revenue $$80.9M-$81.1M, consensus $80.42M

    1/8/2024 - 16:22pm
  • Sight Sciences sees Q4 revenue $18.6M to $18.8M , consensus $18.18M

    1/8/2024 - 16:21pm
  • Piper says Sight Sciences reimbursement update positive, still sees 'work to do'

    12/29/2023 - 09:51am
  • MIGS LCD withdrawals 'takes some upside off table' for Glaukos, says Truist

    12/29/2023 - 07:59am
  • Sight Sciences announces withdrawal of final LCDs on MIGS from five contractors

    12/28/2023 - 09:17am
  • Sight Sciences to share results of Sahara RCT vs Restasis with Medicare/payers

    12/18/2023 - 16:18pm
  • Sight Sciences announces acceptance for publication of GEMINI 2 trial

    12/8/2023 - 08:17am
  • Sight Sciences price target raised to $4 from $3 at Morgan Stanley

    12/4/2023 - 07:06am
dynamic_feed Breaking News